IBDEI0BB ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5105,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,5105,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,5105,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,5106,0)
 ;;=E10.9^^27^329^7
 ;;^UTILITY(U,$J,358.3,5106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5106,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,5106,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,5106,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,5107,0)
 ;;=E11.22^^27^329^8
 ;;^UTILITY(U,$J,358.3,5107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5107,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,5107,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,5107,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,5108,0)
 ;;=E11.9^^27^329^12
 ;;^UTILITY(U,$J,358.3,5108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5108,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,5108,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,5108,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,5109,0)
 ;;=E13.22^^27^329^1
 ;;^UTILITY(U,$J,358.3,5109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5109,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,5109,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,5109,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,5110,0)
 ;;=E83.30^^27^330^26
 ;;^UTILITY(U,$J,358.3,5110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5110,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,5110,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,5110,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,5111,0)
 ;;=E83.31^^27^330^9
 ;;^UTILITY(U,$J,358.3,5111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5111,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,5111,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,5111,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,5112,0)
 ;;=E83.51^^27^330^19
 ;;^UTILITY(U,$J,358.3,5112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5112,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,5112,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,5112,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,5113,0)
 ;;=E83.52^^27^330^13
 ;;^UTILITY(U,$J,358.3,5113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5113,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,5113,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,5113,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,5114,0)
 ;;=E87.0^^27^330^16
 ;;^UTILITY(U,$J,358.3,5114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5114,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
 ;;^UTILITY(U,$J,358.3,5114,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,5114,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,5115,0)
 ;;=E87.1^^27^330^18
 ;;^UTILITY(U,$J,358.3,5115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5115,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,5115,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,5115,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,5116,0)
 ;;=E87.2^^27^330^1
 ;;^UTILITY(U,$J,358.3,5116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5116,1,3,0)
 ;;=3^Acidosis
 ;;^UTILITY(U,$J,358.3,5116,1,4,0)
 ;;=4^E87.2
 ;;^UTILITY(U,$J,358.3,5116,2)
 ;;=^5003020
 ;;^UTILITY(U,$J,358.3,5117,0)
 ;;=E87.3^^27^330^3
 ;;^UTILITY(U,$J,358.3,5117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5117,1,3,0)
 ;;=3^Alkalosis
 ;;^UTILITY(U,$J,358.3,5117,1,4,0)
 ;;=4^E87.3
 ;;^UTILITY(U,$J,358.3,5117,2)
 ;;=^5003021
 ;;^UTILITY(U,$J,358.3,5118,0)
 ;;=E87.4^^27^330^24
 ;;^UTILITY(U,$J,358.3,5118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5118,1,3,0)
 ;;=3^Mixed Acid-Base Balance Disorder
 ;;^UTILITY(U,$J,358.3,5118,1,4,0)
 ;;=4^E87.4
 ;;^UTILITY(U,$J,358.3,5118,2)
 ;;=^5003022
 ;;^UTILITY(U,$J,358.3,5119,0)
 ;;=E86.9^^27^330^31
